BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33669429)

  • 21. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z; Hartman C; Livnat G; Shteinberg M; Elenberg Y
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):282-284. PubMed ID: 30640865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions.
    Tam RY; van Dorst JM; McKay I; Coffey M; Ooi CY
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of commensal proliferating
    Matamouros S; Hayden HS; Hager KR; Brittnacher MJ; Lachance K; Weiss EJ; Pope CE; Imhaus AF; McNally CP; Borenstein E; Hoffman LR; Miller SI
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1605-1610. PubMed ID: 29378945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal complications of cystic fibrosis.
    Borowitz D; Gelfond D
    Curr Opin Pulm Med; 2013 Nov; 19(6):676-80. PubMed ID: 24060981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
    Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
    Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model.
    Bazett M; Bergeron ME; Haston CK
    Sci Rep; 2016 Jan; 6():19189. PubMed ID: 26754178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.
    Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY
    Sci Rep; 2016 May; 6():24857. PubMed ID: 27143104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome.
    Jin D; Wu S; Zhang YG; Lu R; Xia Y; Dong H; Sun J
    Clin Ther; 2015 May; 37(5):996-1009.e7. PubMed ID: 26046242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosis.
    Yule A; Sills D; Smith S; Spiller R; Smyth AR
    Expert Rev Respir Med; 2023; 17(7):547-561. PubMed ID: 37345513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.
    Raghuvanshi R; Vasco K; Vázquez-Baeza Y; Jiang L; Morton JT; Li D; Gonzalez A; DeRight Goldasich L; Humphrey G; Ackermann G; Swafford AD; Conrad D; Knight R; Dorrestein PC; Quinn RA
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32576651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood Loss Leads to Increase in Relative Abundance of Opportunistic Pathogens in the Gut Microbiome of Rabbits.
    Yang J; Zhang J; Zhao C; Gai Z; Mu X; Wang Y; Zhang C; Su Z; Gao L; Zhu D; Zuo Z; Heng X; Zhang L
    Curr Microbiol; 2020 Mar; 77(3):415-424. PubMed ID: 31894374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased Expression of Enterocyte Nutrient Assimilation Genes and Proteins in the Small Intestine of Cystic Fibrosis Mouse.
    De Lisle RC
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):627-34. PubMed ID: 26551319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis.
    Beaufils F; Mas E; Mittaine M; Addra M; Fayon M; Delhaes L; Clouzeau H; Galode F; Lamireau T; Bui S; Enaud R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33348735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
    Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
    J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citizen-science based study of the oral microbiome in Cystic fibrosis and matched controls reveals major differences in diversity and abundance of bacterial and fungal species.
    Willis JR; Saus E; Iraola-Guzmán S; Cabello-Yeves E; Ksiezopolska E; Cozzuto L; Bejarano LA; Andreu-Somavilla N; Alloza-Trabado M; Blanco A; Puig-Sola A; Broglio E; Carolis C; Ponomarenko J; Hecht J; Gabaldón T
    J Oral Microbiol; 2021 May; 13(1):1897328. PubMed ID: 34104346
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
    J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.